.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

CLL

ASH 2020: Results From the Phase 1/2 BRUIN Trial

April 23rd 2021

ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Combination in R/R CLL or SLL

April 23rd 2021

ASH 2020: TRANSCEND-CLL-004 Study: Results of CAR-T Monotherapy in R/R CLL or SLL

April 23rd 2021

ASH 2020: Results From the UNITY-CLL Study of Ublituximab Doublet Versus Chemoimmunotherapy in CLL

April 23rd 2021

Results From the Phase 2 CAPTIVATE Study

April 23rd 2021

ASH 2020: Updated Results from the Murano Five-Year Analysis in R/R CLL

April 23rd 2021

Latest News

Traveling Amid the COVID-19 Pandemic As A Cancer Survivor

The Definition of ‘Extraordinary’

Oncology Nurses Make ‘the Most Difficult Situation … Much Easier’

Immunotherapy Could “Provide A Whole New Realm” For Patients with Myeloma

View More Latest News